Comprehensive Coverage of Clinical Biomarkers:
- Executive ThinkTank on Translational Medicine and Pharmacogenomics
- Tutorial on Biomarker Assay Development and Validation
- Translational Medicine: Decision Making at the Preclinical/Clinical Interface
- Biomarkers for Clinical Safety Assessment and Predicting Adverse Effects
- Effect of Genetic Polymorphisms on Clinical Pharmacology
- PK/PD Biomarkers and Modeling
- Biomarkers to Monitor and Predict Disease Progression and Response to Therapy
- Clinical Validation of Biomarkers: Biological and Analytical
Distinguished Faculty:
Dr. Joseph Ahearn, Director of Research, Medicine, University of Pittsburgh Arthritis Institute
Ms. Cynthia S. Cheesman, Assistant Vice President, Preclinical Project Management, Wyeth
Dr. David Chen, Clinical Research Director, Experimental Medicine, sanofi-aventis
Dr. William Clarke, Professor, Pathology, Johns Hopkins University
Dr. Samuel E. DePrimo, Clinical Research Scientist, Translational Medicine,
Pfizer Global R&D
Dr. Robert T. Dworschack, Director, Clinical Trials, Roche Diagnostics
Dr. Dan Fitzpatrick, Associate Director, Molecular Sciences, Amgen Inc.
Dr. Jean-Michel Gries, US Site Head, Clinical Pharmacology (PDMP), F. Hoffmann-La Roche Inc.
Dr. Dave Hoon, Director, Member, Molecular Oncology, John Wayne Cancer Institute
Dr. Keith Johnson, Senior Director, Research and Development, Pfizer Inc.
Dr. Janet Lathey, Director, Virology/Immunology, SeraCare BioServices
Dr. Pauline Lau, President, Suntec Corporation
Dr. Juan A. Leal, Senior Director, Translational Medicine, Exelixis, Inc.
Dr. Rene H. Levy, Professor & Chair, Pharmaceutics & Neurological Surgery, University of Washington
Dr. Estelle Marrer, Biomarker Expert, Biomarker Development, Novartis Pharma AG
Dr. Bernd Meibohm, Associate Professor of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center
Dr. Anne Nafziger, ORI Drug Development Center, Ordway Research Institute
Dr. Koustubh Ranade, Associate Director, Pharmacogenomics & Human Genetics, Pharmaceutical Research Institute, Bristol-Myers Squibb Co.
Dr. Dan M. Roden, Director, Oates Institute for Experimental Therapeutics, Vanderbilt University School of Medicine
Dr. Brian Ross, Professor, Radiology & Biological Chemistry, University of Michigan
Ms. Olive Wolfe, President, Clinical Consultants, Inc
Prof. Wolfgang Sadee, Chair, Pharmacology, Ohio State University
Dr. Mark Scholz, Medical Director, Clinical Services, Prostate Oncology Specialists
Dr. Somasekar Seshagiri, Scientist, Molecular Biology, Genentech Inc.
Dr. Dennis J. Slamon, Chief, Division of Hematology/Oncology, David Geffen School of Medicine, UCLA
Dr. Sudha Visvanathan, Principal Research Scientist, Clinical Pharmacology and Experimental Medicine, Centocor, Inc.
Prof. Lawrence Wangh, Associate Professor, Biology, Brandeis University
Dr. Feng Wang, Principal Scientist, Procter & Gamble Pharmaceuticals
Dr. Danyi Wen, Scientist II, Inflammation, Millennium Pharmaceuticals, Inc.
Dr. Georg Wensing, Head, Pharmacodynamics, Clinical Pharmacology, Bayer Healthcare